Summary A panel of doxorubicin-resistant sublines of the human small-cell lung carcinoma cell line GLC4 displays decreasing DNA topoisomerase Ila (TopoIla) mRNA levels with increasing resistance. In the present study we describe how this decrease may be regulated. No significant differences in TopoIla mRNA stability or gene arrangement were found, using mRNA slot-blotting and Southern blotting, in the most resistant cell line compared with the parental cell line. To investigate if Topolla gene copy loss contributed to the mRNA decrease, fluorescence in situ hybridisation using a TopoIllx-specific probe was performed. During doxorubicin resistance development, the composition of the population in each cell line shifted with increasing resistance, from a population in which most cells contain three TopoIla gene copies (GLC4) to a population in which most cells contain only two copies. A partial revertant of the most resistant cell line displayed a shift back to the original situation. We conclude that the Topolla gene copy number decrease per cell line is in good agreement with the decreased TopolIa mRNA and protein levels, and Topoll activity levels in these cell lines which were described previously.
The interest in DNA topoisomerases (Topos) has increased after it was found that these essential, DNA conformationcontrolling enzymes are targets for several chemotherapeutic drugs used in cancer treatment (reviewed by D'Arpa and Liu, 1989) . To date one type I DNA topoisomerase (Topol) and two type II DNA topoisomerases (TopollIx and ,B) have been found in human cells. Recently Topolla has been the focus of attention. Although TopolIoc and TopoIIfl display similarities at the sequence level (Austin et al., 1993) , their expression pattern during the cell cycle is different (Kimura et al., 1994) , as is their chromosomal localisation (Tan et al., 1992; Jenkins et al., 1992) and the distribution ofboth proteins in the nucleus (Zini et al., 1994) . Furthermore, it was suggested that Topolla is more sensitive for Topo-targeting drugs than TopoII,B (Drake et al., 1989) and that Topolla-mediated strand breaks contribute most to cytotoxicity (Woessner et al., 1990) . Several reports have been published correlating Topollcx levels with drug sensitivity (Davies et al., 1988; Deffie et al., 1989; Fry et al., 1991) . One of the resistance mechanisms of cancer cells to Topoll-targeting drugs is a reduction of the Topoll protein level. This reduction could be the result of a number of changes at the DNA or RNA level in the resistant cells (for recent reviews see Beck et al., 1993; Pommier et al., 1994) .
In this study we analysed whether changes in the stability of TopolIa mRNA, chromosomal rearrangements of the gene encoding this protein or a decrease in gene copy number per cell explain the decrease in Topolla mRNA in 2-to 150-fold doxorubicin (DOX)-resistant small-cell lung carcinoma cell lines. It was found that the decrease in Topolla mRNA, observed in the DOX-resistant sublines, could be explained by selection for a subpopulation containing a decreased TopoIllI gene copy number.
Materials and methods Cell lines
The parental human SCLC cell line GLC4 was derived from a pleural effusion. The DOX-resistant cell line GLC4/ADR,50,x (the resistance factor to the drug of interest is shown in subscript) was extensively characterised earlier Meijer et al., 1987 Meijer et al., , 1991 De Jong et al., 1990 Withoff et al., 1994; Versantvoort et al., 1995) . Besides changes on the Topo level other resistance mechanisms such as expression of the multidrug resistance associated protein (MRP) (Muller et al., 1994; Versantvoort et al., 1995) contribute partially to DOX resistance in GLC4/ADR,50x. GLC4/ADR2, and GLC4/ADR,ox were isolated during in vitro acquired resistance development against DOX leading to GLC4/ADR150x. GLC4/ADRprio is a partial revertant of GLC4/ADR,50X obtained by culturing the latter cell line without drug for 6 months. Culturing procedures of the DOX-resistant cell lines were described previously (Versantvoort et al., 1995) . The TopoIlcx mRNA and protein levels presented in that study and the Topoll activity published by De Jong et al. (1990) (Sambrook et al., 1989) . After restriction and gel electrophoresis DNA was alkaline transferred from 1% agarose gels onto positively charged nylon membranes (Hybond N+) using 0.6 M sodium chloride/0.4 M sodium hydroxide.
Hybridisation of Southern blots and mRNA slot-blots The Topollcx probe SPI was kindly provided by KB Tan and the c-myc probe by RN Eisenman. Probes were labelled with [32P]dCTP (3000 ci mmol-', Amersham, 's-Hertogenbosch, The Netherlands) using an oligolabelling kit (Pharmacia Biotech BV, Woerden, The Netherlands). Blots were hybridised overnight at 65°C in 0.5 M disodium hydrogen phosphate, pH 7.2, 1 mM EDTA, 7% SDS. Post-hybridisation washes were performed in sequentially 2 x SSC/0.1% SDS, 1 x SCC/0.1% SDS and 0.1 x SSC/0.1% SDS at 65°C for 30 min. Membranes were exposed to Kodak XOmat XAR X-ray film (Brunschwig, Amsterdam, The Netherlands) between intensifying screens at -80°C. Band intensities of mRNA slot-blot signals were determined densitometrically using the UltraScanXL laser densitometer (Pharmacia, Uppsala, Sweden). Topolloc mRNA expression levels were corrected for 28S rRNA expression levels determined after stripping and rehybridisation of the membranes with a 28S probe.
Probes used for FISH The cosmid clone for Topollac (ICRFc1O5bO4155) was developed from the Imperial Cancer Research Fund Reference Library (Lehrach, 1990 In situ hybridisation In situ hybridisation was performed essentially as described before (Nederlof et al., 1992) . Metaphase spreads of the cell lines were fixed in 3:1 methanol, glacial acetic acid for 1 h at room temperature (RT). Lymphocytes were used as a control in each hybridisation. Slides were briefly rinsed with 2 x SSC (1 x SSC is 0.15 M sodium chloride, 0.015 M sodium citrate, pH 7) and treated with 100 jug ml-' RNAase A for 1 h at 37°C. Chromosomes were treated with pepsin (0.01% in 10 mM hydrochloric acid) for 10 min at 37°C. Pepsin-treated chromosomes were post-fixed for 10 min at RT in Streck tissue fixative (Streck Laboratories, Omaha, NE, USA), dehydrated by sequential washings with 70% ethanol and 100% ethanol, and air dried. Chromosomes were denatured by heating in 70% formamide, 2 x SSC at 80°C for 3 min and dehydrated. Probes were denatured for 5 min at 80°C and incubated at 37°C for 15 to 30 min before use, unless stated otherwise by the manufacturer. Denatured probe (10 pl) was added to the slide and hybridisation was performed overnight under a sealed coverslip at 37°C.
Probe detection Probe detection was performed as described before (Kallioniemi et al., 1992) with slight modifications. Slides were washed in 50% formamide, 1 x SSC at 42°C for 20 min, followed by a wash in 2 x SSC, 42°C, 20 min. All the following steps were performed at RT. Biotinylated probes Slides were dehydrated before mounting in Vectashield H1000 anti-fade medium (Vector Labs) containing 0.3 ig ml-' propidium iodide (PI) and 0.1 HIg ml-' 4,6-diamino-indole. Fluorescence was detected using the BioRad MRC-600 laser scanning confocal microscope (Richmond, CA, USA) equipped with a krypton argon laser. Unedited PI staining and probe signals were stored on optical disks and have been retained. Images were processed using edge enhancement algorithms (Comos software, Hemel Hempstead, Bio-Rad, UK) and stored as separate files. PI and probe fluorescence signals were merged using Comos and Nexus software (Bio-Rad). Optimal colour balance of the pseudocolour images was achieved using image processing software (Photomagic, Micrografx, TX, USA). Final figures were annotated in, and directly printed from, Micrografx Draw, using a dye sublimation printer (Colour Ease, Kodak, Harrow, UK).
Results

Stability of TopoIIa. mRNA
In Figure 1 the results obtained for GLC4 and GLC4/ADR,50s are shown. The half-life of TopolIa mRNA in these cell lines is longer than 4 h and similar in both cell lines (Figure la) . The small difference in the angle of the best-fitted lines in Figure la does TopoIIa gene copy number determination using FISH In Figure 3 representative metaphase spreads hybridised with the Topollx probe are presented. It shows that GLC4 contains three copies (Figure 3b ) while the control lymphocytes carry two copies (Figure 3a) Table II and Figure 3 show that the parental cell line, GLC4, has a predominant population of cells containing three TopolIIa gene copies, although a minor qiihnonilation with two conies is nresent. GLC/ADR.. Table I shows that the TopoIIa gene copy number per 100 cells is in agreement with the data obtained by mRNA slot-blot and Western blotting and with the activity assay. Thus, a reduction in gene copy number may at least in part explain the reduced Topollcx in these cell lines.
Discussion
The main reason for Topoll-related drug resistance is a decreased Topolla enzyme level. There is little information on how genetic changes contribute to this decrease. In the DOX-resistant sublines of GLC4 the decrease in TopoIla protein coincided with decreased mRNA levels. As we have not found any indication of an altered (mutated) TopoII being present in GLC4/ADR15ox (De Jong et al., 1993) , the Topolla mRNA decrease may be an important resistance mechanism, especially in the low resistant cell lines. We therefore decided to investigate which mechanism caused the mRNA decrease. Recently, Ritke et al. (1993) described an etoposide-resistant human leukaemia K562 cell line with a 2.5-fold decreased Topolla mRNA level which was due to a 1.7-fold decrease in the stability of the mRNA. However, in the most resistant cell line GLC4/ADR150,, no evidence for a significantly decreased Topollo mRNA stability was found when compared with GLC4. Both the resistant and the sensitive cell line have a comparable long half-life (>4 h) for Topolla mRNA. Ritke et al. (1993) found for K562 Topolla mRNA a half-life shorter than 2 h. To date Ritke's study and ours are the only two describing Topolla mRNA stability data. The half-life of c-myc mRNA in the GLC4 cell lines (0.5 h) was in agreement with that found in earlier publications (Hann et al., 1984) .
It was shown that genetic alterations on Topolloc gene level can influence Topolloe protein expression (Coutts et al., 1993; Keith et al., 1993) . The highly resistant cell line GLC4/ ADRI50t did not show rearrangements in the Topollcx gene using the Southern blot technique. These findings are in contrast with results obtained by Tan et al. (1989) (Tsuji et al., 1994) . We did not intend to study how the additional chromosome 17 copy was gained in GLC4, but were more interested in the decrease of TopoIlLI mRNA during resistance development. This decrease is in contrast with findings obtained for other genes encoding TopolI drug-handling proteins involved in resistance development, which are amplified in drug-resistant tumours and cell lines such as P-glycoprotein and MRP (Lonn et al., 1994; Eijdems et al., 1995) .
In order to investigate when during resistance development this change has taken place we analysed GLC4/ADR2x and GLC4/ADR1ox, which also display decreased Topolla mRNA levels. It was found that with increasing DOX resistance the population composition gradually changes from a population in which most cells contain three Topolla gene copies to a population in which most cells contain only two copies. This change is in agreement with the hypothesis that during resistance development in human tumours, the resistant cells are initially sporadically present in a genetically heterogeneous tumour, and selected by drug exposure (Dexter and Leith, 1986 (Keith et al., 1993; Murphy et al., 1995) . Thus other genes on the same chromosome might be essential for the selection procedure as well. In Table I (Table I) , although the gene copy number decreases only to 67%. The involvement of transcriptional regulation was suggested by Husain et al. (1994) for Topol expression. They presented tumour type-specific differences in TopoI expression and postulated that increased Topol mRNA levels may result from increased transcription or increased mRNA stability.
We do realise that the decrease in TopolIo is not the only resistance mechanism triggered in this cell line panel [Topoll, mRNA levels for instance are also decreased in this cell line panel (Versantvoort et al., 1995) ]. In GLC4/ADR2X however, which may be a better model for resistance development in the clinical situation with its low resistance factor than highly resistant cell lines such as GLC4/ADR150,, the Topolla mRNA decrease may already be an important contribution to resistance. Therefore, we decided to focus on how the decrease in Topolla mRNA is caused. In the present study we show that the decrease in Topolla mRNA level in the DOX-resistant GLC4 cell line panel is caused by a shift in the composition of the population in favour of cells containing fewer than TopolIa gene copies. This decrease results in a decrease in TopolIa protein expression and thus a decrease in drug target in the DOX-resistant cell lines.
